购物车
- 全部删除
您的购物车当前为空
Anti-ICOS ligand Antibody-FITC (9J164)
还可以
产品编号 TMAY-01904F
别名 LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2
Anti-ICOS ligand Antibody-FITC (9J164) 是一种 FITC-conjugated Rabbit 抗体，靶向 ICOS ligand。Anti-ICOS ligand Antibody-FITC (9J164) 可用于 FCM。
Anti-ICOS ligand Antibody-FITC (9J164)
331 Anti-ICOS ligand Antibody-FITC (9J164)
还可以产品编号 TMAY-01904F 别名 LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2
Anti-ICOS ligand Antibody-FITC (9J164) 是一种 FITC-conjugated Rabbit 抗体，靶向 ICOS ligand。Anti-ICOS ligand Antibody-FITC (9J164) 可用于 FCM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 T | ¥ 685 | 5日内发货 | |
| 100 T | ¥ 880 | 5日内发货 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-ICOS ligand Antibody-FITC (9J164) is a FITC-conjugated Rabbit antibody targeting ICOS ligand. Anti-ICOS ligand Antibody-FITC (9J164) can be used in FCM. |
| 别名 | LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2 |
| Ig Type | Rabbit IgG |
| 克隆号 | 9J164 |
| 交叉反应 | Human |
| 验证活性 | Flow cytometric analysis of Human ICOSLG (CD275) expression in RPMI8226 cells. |
| 应用 | FCM |
| 推荐剂量 | 10 μl/Test, 0.1 mg/ml |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human ICOS Ligand / B7-H2 / ICOSLG (rh ICOS Ligand / B7-H2 / ICOSLG; TMPY-01672; NP_056074.1; Met1-Ser258) and conjugated with FITC under optimum conditions, the unreacted FITC was removed. |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | PBS solution containing 0.5% BSA and 0.09% sodium azide |
| 研究背景 | Inducible co-stimulator ligand (ICOSL), also known as B7-H2, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains and binds to ICOS on activated T cells, thus delivers a positive costimulatory signal for optimal T cell function. The structural features of ICOSL are crucial for its costimulatory function. The present study shows that ICOSL displays a marked oligomerization potential, resembling more like B7-1 than B7-2. B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. The CD28/B7 and ICOS/B7-H2 pathways are both critical for costimulating T cell immune responses. Deficiency in either pathway results in defective T cell activation, cytokine production, and germinal center formation.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
| 偶联 | FITC |
| 免疫原 | Recombinant Protein: Human ICOS Ligand / B7-H2 / ICOSLG protein (TMPY-01672) |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets |
存储&运输
| 储存方式 | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal. |
| 运输方式 | Shipping with blue ice. |
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
SCI 文献
评论列表
预览
Related Tags: buy Anti-ICOS ligand Antibody-FITC (9J164) | purchase Anti-ICOS ligand Antibody-FITC (9J164) | Anti-ICOS ligand Antibody-FITC (9J164) cost | order Anti-ICOS ligand Antibody-FITC (9J164)
嗨！有任何问题？点我咨询
评论内容